ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia
Conclusions: These results indicate that ENO2 may be a biological marker for monitoring chemotherapeutic efficacy and relapse in ALL. ENO2 may provide a potential therapeutic strategy for ALL.Cell Physiol Biochem 2018;46:1525 –1535
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Biochemistry | Cancer | Cancer & Oncology | Chemotherapy | Cytology | Genetics | Leukemia | Molecular Biology | Physiology | Study